CD7 and leukemia: Mice (n = 27) were engrafted with 1 × 107 EGFP+LUC+ labelled Jurkat T cells modified to express either CD3 or CD7, alone or in combination, (Supplementary Figure. 9) and 3 days later leukaemia establishment was confirmed by bioluminescent signalling (Fig. 6A).